Carmel Capital Partners LLC Invests $65,000 in Blend Labs, Inc. $BLND

Carmel Capital Partners LLC purchased a new position in shares of Blend Labs, Inc. (NYSE:BLND) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 19,600 shares of the company’s stock, valued at approximately $65,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. grew its stake in Blend Labs by 4.6% in the 1st quarter. Vanguard Group Inc. now owns 17,586,601 shares of the company’s stock valued at $58,915,000 after buying an additional 775,091 shares during the last quarter. Metavasi Capital LP grew its stake in Blend Labs by 15.6% in the 1st quarter. Metavasi Capital LP now owns 5,554,101 shares of the company’s stock valued at $18,606,000 after buying an additional 750,000 shares during the last quarter. Whitebark Investors LP grew its stake in Blend Labs by 4.6% in the 2nd quarter. Whitebark Investors LP now owns 4,853,883 shares of the company’s stock valued at $16,018,000 after buying an additional 214,609 shares during the last quarter. EdgePoint Investment Group Inc. grew its stake in Blend Labs by 28.2% in the 1st quarter. EdgePoint Investment Group Inc. now owns 3,318,924 shares of the company’s stock valued at $11,118,000 after buying an additional 729,512 shares during the last quarter. Finally, Next Century Growth Investors LLC grew its stake in Blend Labs by 1.6% in the 1st quarter. Next Century Growth Investors LLC now owns 1,521,648 shares of the company’s stock valued at $5,098,000 after buying an additional 23,777 shares during the last quarter. 52.56% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Blend Labs

In other news, insider Brian Kneafsey sold 25,000 shares of the firm’s stock in a transaction dated Wednesday, October 15th. The shares were sold at an average price of $3.34, for a total transaction of $83,500.00. Following the completion of the transaction, the insider directly owned 687,909 shares of the company’s stock, valued at approximately $2,297,616.06. This trade represents a 3.51% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Nima Ghamsari sold 311,886 shares of the firm’s stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $2.90, for a total transaction of $904,469.40. Following the transaction, the insider directly owned 5,754,051 shares of the company’s stock, valued at $16,686,747.90. The trade was a 5.14% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 361,886 shares of company stock valued at $1,059,719 over the last ninety days. 35.52% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on BLND shares. Keefe, Bruyette & Woods lowered their target price on shares of Blend Labs from $4.00 to $3.75 and set a “market perform” rating on the stock in a research note on Friday, August 8th. Wall Street Zen upgraded shares of Blend Labs from a “sell” rating to a “hold” rating in a research note on Sunday, August 17th. UBS Group reduced their price target on shares of Blend Labs from $4.00 to $3.50 and set a “neutral” rating for the company in a report on Friday, August 8th. Canaccord Genuity Group reissued a “buy” rating and issued a $5.25 price target on shares of Blend Labs in a report on Friday, August 22nd. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Blend Labs in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $4.88.

Blend Labs Price Performance

Shares of Blend Labs stock opened at $3.32 on Friday. The firm has a fifty day moving average price of $3.58 and a two-hundred day moving average price of $3.47. The company has a market cap of $860.77 million, a PE ratio of -22.10 and a beta of 1.24. Blend Labs, Inc. has a fifty-two week low of $2.63 and a fifty-two week high of $5.53.

Blend Labs (NYSE:BLND) last released its quarterly earnings data on Thursday, August 7th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.05). The firm had revenue of $31.52 million for the quarter, compared to the consensus estimate of $31.93 million. Blend Labs has set its Q3 2025 guidance at EPS. Analysts expect that Blend Labs, Inc. will post -0.19 earnings per share for the current fiscal year.

About Blend Labs

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.